| Model ID | 12-034-04 |
| Model Name | Wang 2012 - 30 Day Imminent Death |
| Pubmed ID | 22819429 |
| First Author | Wang |
| Journal | American Journal of Cardiology |
| Year | 2012 |
| Title | Predicting risk of hospitalization or death among patients with heart failure in the veterans health administration |
| Primary Index Condition | Chronic Heart Failure (CHF) |
| Secondary Index Condition | N/A |
| Outcome | Mortality |
| Model Sample Size | 198640 |
| Cohort Sample Size | 198640 |
| Number of Events | 1788 |
| Follow-Up Duration | Short (<3 months) |
| AUROC | 0.8 |
| Calibration Reported | 1 |
| Covariates | Age (years) 18-55; Age (years) 55-65; Age (years) 65-75; Age (years) 75-80; Age (years) 80-85; Age (years) >85; Male vs female; Married currently; Service connection >=50% vs <50%; VA priority groups 1 vs 6 to 8; VA priority groups 2,3 vs 6 to 8; VA priority groups 4 vs 6 to 8; VA priority groups 5 vs 6 to 8; Age >=65 years; Deyo-Charlson Index; Respiratory failure; Valvular heart disease; Respiratory failure * valvular heart disease; Renal failure; Chronic obstructive pulmonary diseases (COPD); Dementia; Hospitalized in the prior year; Pneumonia; Peripheral vascular disease; Metastatic cancer; Liver disease; Atrial fibrillation; Systolic blood pressure 110-140 vs <110; Systolic blood pressure >140 vs <110; Diastolic blood pressure 60-89 vs <60; Diastolic blood pressure >=90 vs <60; Heart rate 60-85 vs <60; Heart rate >85 vs <60; Respiration 18-20 vs <18; Respiration >20 vs <18; Body mass index (BMI) 25-29 vs <25; BMI 29-35 vs <25; BMI 35+ vs <25; BMI missing vs <25; Emergency visits (1 year): 1 vs 0; Emergency visits (1 year): 2 vs 0; Emergency visits (1 year): 3,4 vs 0; Emergency visits (1 year): 5+ vs 0; Primary care visits (1 year): 1,2 vs 0; Primary care visits (1 year): 3,4 vs 0; Primary care visits (1 year): 5+ vs 0; Cardiology visits (1 year): 1+ vs 0; Mental health visits (1 year): 1-3 vs 0; Mental health visits (1 year): 4+ vs 0; Phone visits (1 year): 1-3 vs 0; Phone visits (1 year): 4+ vs 0; Other nonface visits (1 year): 1,2 vs 0; Other nonface visits (1 year): 3-9 vs 0; Other nonface visits (1 year): 10-15 vs 0; Other nonface visits (1 year): 16+ vs 0; Other visits (1 year): 1-3 vs 0; Other visits (1 year): 4-9 vs 0; Other visits (1 year): 10-29 vs 0; Other visits (1 year): 30+ vs 0; Outpatient visits (1 year): 6-10 vs 0-5; Outpatient visits (1 year): 11-19 vs 0-5; Outpatient visits (1 year): 20-29 vs 0-5; Outpatient visits (1 year): 30+ vs 0-5; Emergency visits (1 month): 1+ vs 0; Cardiology visits (1 month): 1+ vs 0; Other nonface (1 month): 1 vs 0; Other nonface (1 month): 2+ vs 0; Other visits (1 month): 1 vs 0; Other visits (1 month): 2+ vs 0; Outpatient visits (1 month): 1 vs 0; Outpatient visits (1 month): 2 vs 0; Outpatient visits (1 month): 3+ vs 0; Mental health hospitalizations (1 year): 1+ vs 0; All hospitalizations (1 year): 1 vs 0; All hospitalizations (1 year): 2 vs 0; All hospitalizations (1 year): 3 vs 0; All hospitalizations (1 year): 4 vs 0; All hospitalizations (1 year): 5+ vs 0; Number providers: 2 vs 1; Number providers: 3,4 vs 1; Number providers: 5,6 vs 1; Number providers: 7+ vs 1; Number of refills: 1-14 vs 0; Number of refills: 15-22 vs 0; Number of refills: 23-31 vs 0; Number of refills: 32-45 vs 0; Number of refills: 46+ vs 0; ACEI/ARB; Hospitalized * ACEI/ARB; Anticholinergics; Antidepressants; Antipsychotics; Benzodiazepines; Beta blockers; Hospitalized * Beta blockers; Bumetanide; Digoxin; Furosemide; Statins; Metformin; Metolazone; Nitrates; Opioid narcotics; Hospitalized * opioid narcotics; Non-steroidal anti-inflammatory drugs (NSAID); Oral steroids; Torsemide; Warfarin; No laboratory test in last year; Albumin (g/dL): 2.5-3.5 vs >=3.5; Albumin (g/dL): <2.5 vs >=3.5; Albumin not tested vs >=3.5; Blood urea nitrogen (mg/dL): 17-25 vs <17; Blood urea nitrogen (mg/dL): 25-40 vs <17; Blood urea nitrogen (mg/dL): >40 vs <17; Blood urea nitrogen not tested vs. <17; Potassium (mEq/L): <3.5 vs 3.5-6; Potassium (mEq/L): >6 vs 3.5-6; Potassium not tested vs 3.5-6; WBC (k/mm^3): <2 vs 2-14; WBC (k/mm^3): >14 vs 2-14; WBC not tested vs 2-14; Intercept |
| Mesh Terms | To be updated |
| Number of Validations | 0 |
